Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price ...

Investing.com -- Shares of Bayer AG (ETR: BAYGN) were up over 5% on Thursday after Goldman Sachs upgraded the German pharmaceutical and life sciences company to a "buy" rating from "neutral ...

Bayer upgraded to Buy at Goldman Sachs, saying risk/reward into H2 2025 looks positive and catalysts including upcoming ...

On Thursday, Goldman Sachs analysts upgraded Bayer AG (ETR:BAYGN) (BAYN:GR) (OTC: BAYRY) stock from Neutral to Buy. The new price target is set at €33.00, up from the previous €29.10.

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Find insight on Bayer and more in the latest Market Talks covering the Health Care sector.